SCHEMBL12850767

SCHEMBL12850767

Cc1c(-c2ccc(O)cc2)nc2[nH]c3ccccc3n12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ USP2 O75604 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ADORA2A P29274 3/20 0.42
▸ ADORA1 P30542 3/20 0.42
▸ ADORA3 P0DMS8 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MAP2K4 P45985 1/20 0.40
▸ MAPKAPK2 P49137 1/20 0.40
▸ MAPK6 Q16659 1/20 0.40
▸ MGAM O43451 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ SI P14410 1/20 0.40
▸ MGAM2 Q2M2H8 1/20 0.40
▸ PDE2A O00408 1/20 0.39
▸ PDE6D O43924 1/20 0.39
▸ PDE8A O60658 1/20 0.39
▸ PDE5A O76074 1/20 0.39
▸ PDE9A O76083 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20893121 0.88 ADORA2A (0.47) MAPTKMT2AADORA2AADORA1ADORA3
SCHEMBL12968544 0.85 BRAF (0.41) MAPTKMT2AADORA2AADORA1ADORA3
SCHEMBL16021113 0.84 ADORA3 (0.49) MAPTNPSR1ADORA1ADORA3MAPK1
SCHEMBL29033149 0.74 PDE2A (0.41) MAPTKMT2ANPSR1ADORA2AADORA3
SCHEMBL20893214 0.73 KDM4E (0.44) MAPTKMT2AADORA2AADORA1ADORA3
SCHEMBL9416616 0.72 POLB (0.44) MAPTKMT2AADORA1ADORA3GAA
SCHEMBL20893059 0.71 KDM4E (0.41) MAPTADORA2AADORA1ADORA3MAPK1
SCHEMBL9416648 0.70 ADORA3 (0.44) MAPTKMT2AADORA1ADORA3GAA
SCHEMBL9264212 0.70 ADORA3 (0.41) MAPTKMT2AADORA1ADORA3GAA
SCHEMBL9264131 0.69 KMT2A (0.47) MAPTKMT2AUSP2ADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications EIF4A1, ITPR2, ITPR1 MAPT 1159/4885KMT2A 811/4885USP2 4480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback